Report Categories
View AllRecent Articles
View All
Is Progress Prgs Stock Underperforming Price At 26.76 Down 2.41 20260410
Jblu Stock Analysis Jetblue Airways Corporation 4.52 Minor Airline Dip Performance Review 20260403
Is Cra Crai Stock A Top Performer Price At 165.10 Up 0.67 20260402
Ryn Q4 Earnings Beats Estimates By 0.08 20260403
Is Doordash Dash Stock Tied To Economic Cycles Price At 156.45 Up 3.95 20260402
Enlight ENLT Future Outlook Enlight Renewable Energy Ltd posts 867 EPS miss vs estimates
Airbnb ABNB Stock Is It a Good Buy Drifts Higher 20260418
GRDX GridAI Technologies Corp gains double digits despite posting a far wider than expected Q3 2024 per share loss
Mister Car MCW Stock Float Smart Money Active 20260418
How ChicagoRivet CVR adapts when conditions change Gains 20260508
How Yueda YDKG responds when competition intensifies 1508 20260508
NKTX Nkarta Inc reports wider than expected Q4 2025 loss shares jump nearly 16 percent on upbeat investor sentiment
RZLT Rezolute Inc drops 226 after Q1 2026 earnings report reveals wider than expected pershare loss
Newegg NEGG Stock MA Crossover Market Focus 20260418
FSBC Five Star posts a 68 percent Q4 2025 EPS beat as its stock slips 052 percent in todays session
The growth trajectory NPK International NPKI is on and where it leads Trend Weakens 20260506
ALKT Alkami shares climb 241 percent following Q1 2026 earnings despite 133 percent EPS miss against consensus estimates
Invesco Optimum Yield Diversified Commodity Strategy No K1 ETF PDBC 35 YTD Rally Masks High Uncertainty in 2026 December Distribution Profile
What closed end fund Terns Pharmaceuticals TERN Motionless 20260429
Serina Therapeutics SER Stock Is It a Strong Investment Pick Q4 2025 Earnings Beat Estimates
Should you add Green GCDT to your watchlist today 134 20260506
The growth trajectory NPK International NPKI is on and where it leads Trend Weakens 20260506
The key risks discussed in PetMed Express PETS earnings Q1 2026 Profit Disappoints
The edge Old ORI has in a competitive landscape Eye on Rally 20260508
What above average volume Institutional Selling 20260429
PCSA Processa Pharmaceuticals shares gain nearly 2 percent despite wider than expected Q4 2025 per share loss
Should you add X XYF to your watchlist today Buying Pressure 20260506